Agios Pharmaceuticals, Inc.
AGIO
$27.42
-$0.07-0.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.41% | 42.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.41% | 42.73% | |||
| Cost of Revenue | -5.52% | 26.84% | |||
| Gross Profit | 6.89% | -24.71% | |||
| SG&A Expenses | -10.02% | 10.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.00% | 20.94% | |||
| Operating Income | 8.02% | -19.16% | |||
| Income Before Tax | 7.67% | -25.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7.67% | -25.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.67% | -25.46% | |||
| EBIT | 8.02% | -19.16% | |||
| EBITDA | 8.19% | -19.41% | |||
| EPS Basic | 7.99% | -24.43% | |||
| Normalized Basic EPS | 7.99% | -24.43% | |||
| EPS Diluted | 7.94% | -24.43% | |||
| Normalized Diluted EPS | 7.99% | -24.43% | |||
| Average Basic Shares Outstanding | 0.36% | 0.82% | |||
| Average Diluted Shares Outstanding | 0.36% | 0.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||